Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Real-World Analysis of Belantamab Mafodotin Dosing Patterns in Patients with Relapsed and/or Refractory Multiple Myeloma
Research Grant
Duke Scholars
Principal Investigator
Thomas William LeBlanc
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
GlaxoSmithKline
Start Date
July 18, 2023
End Date
July 30, 2025
Awarded By
GlaxoSmithKline
Start Date
July 18, 2023
End Date
July 30, 2025
